Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 8/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | CDK1 | P06493 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6539669 | 0.89 | KDM4E (0.41) | KDM4EALDH1A1POLBMAPTCYP2C9 | |
| SCHEMBL6538882 | 0.86 | HPGD (0.40) | KDM4EALDH1A1POLBMAPTCYP2C9 | |
| SCHEMBL6539945 | 0.86 | PTGS2 (0.39) | KDM4EALDH1A1POLBMAPTCYP2C9 | |
| SCHEMBL6538959 | 0.86 | PPARD (0.40) | KDM4EALDH1A1POLBMAPTCYP2C9 | |
| SCHEMBL6229912 | 0.86 | PPARD (0.40) | KDM4EALDH1A1POLBMAPTCYP2C9 | |
| SCHEMBL6539632 | 0.85 | ESR2 (0.45) | KDM4EALDH1A1POLBMAPTHPGD | |
| SCHEMBL6206651 | 0.84 | NPSR1 (0.47) | ALDH1A1MAPTHPGDPPARD | |
| SCHEMBL6229835 | 0.81 | KMT2A (0.39) | KDM4EALDH1A1POLBMAPTCYP2C9 | |
| SCHEMBL6539414 | 0.80 | PPARD (0.43) | KDM4EALDH1A1POLBMAPTCYP2C9 | |
| SCHEMBL13352330 | 0.80 | CYP11B1 (0.42) | KDM4EALDH1A1POLBMAPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040157891-A1 | Inhibitor of cox | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157891-A1 | Inhibitor of cox | PTGS1, PTGS2, PTGES2 | KDM4E 1912/4885ALDH1A1 163/4885POLB 2793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.